CRVOInvestor•globenewswire•
CervoMed to Participate in Upcoming Investor Conferences
Sentiment:Negative (20)
Summary
(NASDAQ:CRVO) BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company management will participate in the following investor conferences during the month of September:
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 3, 2025 by globenewswire